06th week of 2019 patent applcation highlights part 9 |
Patent application number | Title | Published |
20190038566 | BEXAROTENE SOFTGEL CAPSULE AND PREPARATION METHOD THEREOF | 2019-02-07 |
20190038567 | ENCAPSULATING AGENT WITH IMPROVED PROPERTIES ADAPTED FOR CELL ENCAPSULATION | 2019-02-07 |
20190038568 | DELIVERY SYSTEMS | 2019-02-07 |
20190038569 | Multifunctional-reinforced dressing | 2019-02-07 |
20190038570 | SUBLINGUAL AND BUCCAL FILM COMPOSITIONS | 2019-02-07 |
20190038571 | Orally Available Small Molecules to Inhibit the Function of the Complement System | 2019-02-07 |
20190038572 | COMPOSITION INCLUDING 3-BROMO-4, 5-DIHYDROXYBENZALDEHYDE COMPOUND AS EFFECTIVE COMPONENT FOR PROTECTING AND TREATING SKIN CELL AGAINST ULTRAVIOLET | 2019-02-07 |
20190038573 | ION CHANNEL ACTIVATORS AND METHODS OF USE | 2019-02-07 |
20190038574 | NANOPARTICLE TARGETED DRUG DELIVERY TO THE LUNGS USING EXTRA-TESTICULAR SERTOLI CELLS | 2019-02-07 |
20190038575 | Methods for Protecting Cells During Cancer Therapy | 2019-02-07 |
20190038576 | Chemosensory Receptor Ligand-Based Therapies | 2019-02-07 |
20190038577 | SNACKING PRODUCT WITH CAPSAICIN OR ANALOGUE THEREOF | 2019-02-07 |
20190038578 | Necrosis Inhibitors | 2019-02-07 |
20190038579 | SHIKIMATE ANALOGUES AND METHODS OF USE | 2019-02-07 |
20190038580 | PHENYLKETONE CARBOXYLATE COMPOUNDS AND PHARAMCEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS | 2019-02-07 |
20190038581 | Treatment of intrahepatic cholestatic diseases | 2019-02-07 |
20190038582 | COMPOSITIONS AND METHODS FOR INHIBITING KINASE ACTIVITY | 2019-02-07 |
20190038583 | METHODS AND COMPOSITIONS FOR INCREASING THE ANAEROBIC WORKING CAPACITY IN TISSUES | 2019-02-07 |
20190038584 | CARCINOMA DIAGNOSIS AND TREATMENT, BASED ON ODC1 GENOTYPE | 2019-02-07 |
20190038585 | FATTY ACID TREATMENT FOR CARDIAC PATIENTS | 2019-02-07 |
20190038586 | ORAL FORMULATIONS OF BIPOLAR TRANS CAROTENOIDS | 2019-02-07 |
20190038587 | DNA Methylation Landscapes of Post-Traumatic Stress Disorder (PTSD) Susceptibility and Resilience and Novel Therapeutics of PTSD Derived Thereof | 2019-02-07 |
20190038588 | NOVEL CLASS OF COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE | 2019-02-07 |
20190038589 | COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISEASE | 2019-02-07 |
20190038590 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA | 2019-02-07 |
20190038591 | USE OF A FASTING MIMICKING DIET TO ENHANCE THE EFFICACY OF ANTIESTROGENS IN CANCER | 2019-02-07 |
20190038592 | PACLITAXEL PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL PREPARATION THEREOF, PREPARATION PROCESS AND USE THEREOF | 2019-02-07 |
20190038593 | SUSPENSION COMPOSITIONS OF PHYSIOLOGICALLY ACTIVE PHENOLIC COMPOUNDS & METHODS OF MAKING AND USING THE SAME | 2019-02-07 |
20190038594 | COMPOUNDS AND USES THEREOF | 2019-02-07 |
20190038596 | GLUCOSE CONJUGATES OF TRIPTOLIDE, ANALOGS AND USES THEREOF | 2019-02-07 |
20190038597 | PREVENTION OF VASCULAR AND CARDIAC FIBROSIS VIA IRE1ALPHA INHIBITION | 2019-02-07 |
20190038598 | PHARMACEUTICAL COMPOSITION INCLUDING DORZOLAMIDE AND BRIMONIDINE | 2019-02-07 |
20190038599 | TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY A BETA-BLOCKER | 2019-02-07 |
20190038600 | MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DEISEASES | 2019-02-07 |
20190038601 | USE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE(III)] FOR THE TREATMENT OF CANCER | 2019-02-07 |
20190038602 | GRANZYME B INHIBITOR FORMULATIONS AND METHODS FOR THE TREATMENT OF BURNS | 2019-02-07 |
20190038603 | METHODS OF TREATING DISEASES CHARACTERISED BY VASOCONSTRICTION | 2019-02-07 |
20190038604 | BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF | 2019-02-07 |
20190038605 | PHARMACEUTICAL COMPOSITION COMPRISING RAPAMYCIN OR DERIVATIVE THEREOF | 2019-02-07 |
20190038606 | USE OF GABOXADOL IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS | 2019-02-07 |
20190038607 | CHEMICAL COMPOUNDS | 2019-02-07 |
20190038608 | SUCCINATE SALT OF CYTISINE AND USE THEREOF | 2019-02-07 |
20190038609 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | 2019-02-07 |
20190038610 | CANCER THERAPY | 2019-02-07 |
20190038611 | Novel CYP34A-Specific Inhibitors and Methods of Using Same | 2019-02-07 |
20190038612 | N3,N6-BIS(2-(5-METHOXY-1H-INDOLE-3-YL)ETHYL)-2,6-DIMETHYL-4-(2-NITROPHENYL- )PYRIDINE-3,5-DICARBOXAMIDE AND USE THEREOF IN THE FIELD OF NEUROTOXICITY | 2019-02-07 |
20190038613 | COMBINATION THERAPY | 2019-02-07 |
20190038614 | PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR | 2019-02-07 |
20190038615 | PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF | 2019-02-07 |
20190038616 | ANTI-NEUTROPHIL ACTIVITY ON INNATE IMMUNE RESPONSE | 2019-02-07 |
20190038617 | METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS | 2019-02-07 |
20190038618 | MORPHINAN COMPOUNDS | 2019-02-07 |
20190038619 | PRODUCT AND METHOD FOR TREATING DIARRHEA | 2019-02-07 |
20190038621 | POSACONAZOLE DERIVATIVE, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2019-02-07 |
20190038622 | NEUROPROTECTIVE AGENTS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2019-02-07 |
20190038623 | THERAPEUTIC REGIMENS FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | 2019-02-07 |
20190038624 | USE OF ABELSON TYROSINE KINASE INHIBITOR IN TREATMENT OF MULTIPLE SYSTEM ATROPHY | 2019-02-07 |
20190038625 | INHIBITORS AND THEIR USES | 2019-02-07 |
20190038626 | HEAT SHOCK PROTEIN BINDING COMPOUNDS, COMPOSITIONS, AND METHODS FOR MAKING AND USING SAME | 2019-02-07 |
20190038627 | METHANOCARBA DERIVATIVES OF PSEUDORIBOSE THAT INHIBIT ADENOSINE KINASE | 2019-02-07 |
20190038628 | USE OF INHIBITORS OF THE ACTIVITY OR FUNCTION OF PI3K FOR THE TREATMENT OF PRIMARY SJOGREN'S SYNDROME | 2019-02-07 |
20190038629 | CONCENTRATED METHOTREXATE SOLUTIONS | 2019-02-07 |
20190038630 | USE OF ADENOSINE RECEPTOR SIGNALING TO REGULATE P-GP FUNCTION | 2019-02-07 |
20190038631 | 6-AMINO-PURIN-8-ONE COMPOUNDS | 2019-02-07 |
20190038632 | COPANLISIB BIOMARKERS | 2019-02-07 |
20190038633 | METHODS OF TREATING CANCER | 2019-02-07 |
20190038634 | PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2-(1-HYDROXY-ALKYL)-CHROMEN-4-ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS | 2019-02-07 |
20190038635 | SOLID DOSAGE FORMULATIONS OF AN OREXIN RECEPTOR ANTAGONIST | 2019-02-07 |
20190038636 | Use of Medications with Neuroprotective Properties to Prevent or Reduce the Risk of Ischemia-Reperfusion Injury in a Subject | 2019-02-07 |
20190038637 | Use of Hydroxyprogesterone Derivatives for Enhanced Health and Physical Performance II | 2019-02-07 |
20190038638 | FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF | 2019-02-07 |
20190038639 | METHODS OF TREATING EPILEPSY OR STATUS EPILEPTICUS | 2019-02-07 |
20190038640 | COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING | 2019-02-07 |
20190038641 | COMBINATION THERAPY FOR CASTRATION-RESISTANT PROSTRATE CANCER | 2019-02-07 |
20190038642 | TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS | 2019-02-07 |
20190038643 | Hydrogen Sulfide (H2S) Releasing Donor Compound For Dermal Wound Regeneration | 2019-02-07 |
20190038644 | PREPARATION FOR NASAL-NASOPHARYNGEAL TREATMENT | 2019-02-07 |
20190038645 | AGENT FOR OVERCOMING IMMUNOSUPPRESSION AND USE THEREOF | 2019-02-07 |
20190038646 | METHODS, AGENTS, AND DEVICES FOR LOCAL NEUROMODULATION OF AUTONOMIC NERVES | 2019-02-07 |
20190038647 | METHOD OF TREATING HEART FAILURE | 2019-02-07 |
20190038648 | MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING BACTERIAL INFECTIONS AND RELATED SYMPTOMS | 2019-02-07 |
20190038649 | MEDICAMENT FOR USE IN TREATING DIABETES | 2019-02-07 |
20190038650 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROSIS AND HEPATOSTEATOSIS AND OTHER DISEASES | 2019-02-07 |
20190038651 | USE OF FLORIDOSIDE OR ISETHIONIC ACID TO POTENTIATE ANTIMICROBIAL ACTIVITY OF ANTIBIOTICS | 2019-02-07 |
20190038652 | EFFECTS OF LGM2605 ON A PRIMATE MODEL OF ASTHMA | 2019-02-07 |
20190038653 | COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISEASES | 2019-02-07 |
20190038654 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2019-02-07 |
20190038655 | CHEMICALS AND METHODS TO PREVENT AND TREAT TGF-BETA MEDIATED ACTIVATION OF FIBROBLASTS TO REDUCE AND TREAT CANCER AND FIBROSIS | 2019-02-07 |
20190038656 | ANTHRANILYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF | 2019-02-07 |
20190038657 | COMPOSITIONS AND METHODS FOR TREATING FIBROTIC DISEASE | 2019-02-07 |
20190038658 | HIGH DENSITY LIPOPROTEIN BINDING PROTEIN (HDLBP/VIGILIN) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 2019-02-07 |
20190038659 | METHODS OF TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS | 2019-02-07 |
20190038660 | SYNTHETIC PROMOTERS AND USES THEREOF | 2019-02-07 |
20190038661 | NEW COMPOSITIONS | 2019-02-07 |
20190038662 | Hydroxypropyl Beta-Cyclodextrin Compositions and Methods | 2019-02-07 |
20190038663 | DECARBOXYLATED CANNABIS RESINS, USES THEREOF AND METHODS OF MAKING SAME | 2019-02-07 |
20190038664 | SOLID PREPARATION, METHOD FOR PRODUCING SOLID PREPARATION, AND METHOD FOR GENERATING HYDROGEN | 2019-02-07 |
20190038665 | PLANT MEDIUM INCLUDING AN OXYGEN-ENABLED COMPOSITION | 2019-02-07 |
20190038666 | TUNGSTATE TREATMENT OF THE DYSBIOSIS ASSOCIATED WITH GASTROINTESTINAL INFLAMMATION | 2019-02-07 |
20190038667 | APPLICATION OF FULLERENE/METAL-FULLERENE FOR PREPARING PHARMACEUTICAL PRODUCT | 2019-02-07 |